The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration’s vaccine chief was pushed out.
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...